Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Heckman James Charles Jr — Paradium.AI, Inc. insider: 1 transactions · InsiderLens

/ / Heckman James Charles Jr

Heckman James Charles Jr

See Remarks at China Pharmaceuticals Inc · on record since Jan 30, 2024
Director at RTB Digital, Inc. · on record since Jun 15, 2026
Chief Executive Officer at RTB Digital, Inc. · on record since Jun 15, 2026
Chief Executive Officer at Paradium.AI, Inc. · on record since Nov 9, 2016
Director at Paradium.AI, Inc. · on record since Jun 19, 2018
10% owner at Paradium.AI, Inc. · on record since Jun 19, 2018

Insider trading activity of Heckman James Charles Jr

Transactions on record: 1; since Jun 19, 2018

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 19, 2018

Figures computed from official regulatory filings — .

Companies where Heckman James Charles Jr has traded

Paradium.AI, Inc.1 tx · $774.5B · Jun 19, 2018

Track record of Heckman James Charles Jr

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Heckman James Charles Jr

Co-insiders of Heckman James Charles Jr

Allred Herbert HuntChina Pharmaceuticals Inc +1
Bailey David FParadium.AI, Inc. +1
Barrett Henry RobertsonChina Pharmaceuticals Inc +1
BRF Investments, LLCChina Pharmaceuticals Inc +1
B. Riley Financial, Inc.China Pharmaceuticals Inc +1
B. RILEY PRINCIPAL INVESTMENTS, LLCChina Pharmaceuticals Inc +1
Edmondson Paul TaylorChina Pharmaceuticals Inc +1
Kraft Andrew Q.China Pharmaceuticals Inc +1
Lee Laura AnneChina Pharmaceuticals Inc +1
Levinsohn RossChina Pharmaceuticals Inc +1
Marchisotto JillChina Pharmaceuticals Inc +1
Petzel ChristopherChina Pharmaceuticals Inc +1
RILEY BRYANT RChina Pharmaceuticals Inc +1
Shribman DanielChina Pharmaceuticals Inc +1
Sims Todd D.China Pharmaceuticals Inc +1
Smith Douglas BakerChina Pharmaceuticals Inc +1

This page republishes public regulatory disclosures.

Sornsin William Carrier JrParadium.AI, Inc. +1

STROME MARK EChina Pharmaceuticals Inc +1

Zimak AviChina Pharmaceuticals Inc +1

Zola CarloChina Pharmaceuticals Inc +1

Adams David HParadium.AI, Inc.

Alexander Michael LewisRTB Digital, Inc.

Baer GenevieveRTB Digital, Inc.

Bhargava ManojChina Pharmaceuticals Inc

BOWERING TERRY GChina Pharmaceuticals Inc

BRC Partners Management GP, LLCParadium.AI, Inc.

BRC Partners Opportunity Fund, LPParadium.AI, Inc.

BR Dialectic Capital Management, LLCParadium.AI, Inc.

BRF Finance Co., LLCParadium.AI, Inc.

B. RILEY CAPITAL MANAGEMENT, LLCParadium.AI, Inc.

B. Riley Securities, Inc.China Pharmaceuticals Inc

Browndorf TodRTB Digital, Inc.

Caragol William JRTB Digital, Inc.

Cheng ZaizhiChina Pharmaceuticals Inc

Christoforatos SpiridonChina Pharmaceuticals Inc

Chung Benjamin JRTB Digital, Inc.

Comer James Lamar WaltonRTB Digital, Inc.

Corrao MarkChina Pharmaceuticals Inc

Croupe DanteRTB Digital, Inc.

Cuilty Sonia ConcepcionRTB Digital, Inc.

Dialectic Antithesis Partners L PParadium.AI, Inc.

Dollar JacquelineRTB Digital, Inc.

Dorsett Jason ChristopherRTB Digital, Inc.

Errez BenRTB Digital, Inc.

FICHTHORN JOHNParadium.AI, Inc.

Fletcher Steven C.RTB Digital, Inc.

Fowler ChristopherChina Pharmaceuticals Inc

Frankl JasonChina Pharmaceuticals Inc

GreenBox POS LLCRTB Digital, Inc.

Haller KennethRTB Digital, Inc.

Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
Paradium.AI, Inc.Listing on record	Jun 19, 2018	BuyD (derivative)	774,473	1,000,000.00 USD	$774.5B	ClusterFirst in 12mo	SEC